GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Option Care Health OPCH · USD

Health Care · US listing · 🇺🇸 United States

Compare

31.69

+0.13%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$5.65bn

FY2016FY2025

Net income

$207.6m

FY2016FY2025

Free cash flow

$217.1m

FY2016FY2025

Shareholders' equity

$1.33bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$5.65bn$5.00bn$4.30bn$3.94bn$3.44bn$3.03bn$2.31bn$1.94bn$817.2m$935.6m
Operating income$337.9m$321.8m$365.8m$240.2m$190.8m$110.8m−$4.5m$38.3m$38.6m−$36.2m
Net income$207.6m$211.8m$267.1m$150.6m$139.9m−$8.1m−$75.9m−$6.1m−$64.2m−$42.8m
Diluted earnings per share1.301.251.500.820.76-0.05-0.43-0.04-0.40-0.29

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$3.46bn$3.42bn$3.33bn$3.23bn$2.79bn$2.65bn$2.59bn$583.9m$605.9m$607.7m
Cash and short-term investments$232.6m$412.6m$343.8m$294.2m$119.4m$99.3m$67.1m$14.5m$39.5m$9.6m
Total liabilities$2.13bn$2.02bn$1.91bn$1.85bn$1.62bn$1.63bn$1.68bn$727.9m$687.0m$639.3m
Debt$1.16bn$1.11bn$1.06bn$1.06bn$1.07bn$1.12bn$1.29bn$504.7m$480.6m$451.9m
Shareholders' equity$1.33bn$1.40bn$1.42bn$1.39bn$1.18bn$1.02bn$906.8m−$144.0m−$81.1m−$31.6m
Shares outstanding160m170m178m183m184m178m177m160m159m147m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$258.4m$323.4m$371.3m$267.5m$208.6m$127.4m$39.5m−$20.1m−$1.1m−$35.2m
Capital spending−$41.3m−$35.6m−$41.9m−$35.4m−$25.6m−$26.9m−$28.3m−$13.9m−$8.4m−$9.6m
Free cash flow$217.1m$287.8m$329.4m$232.2m$182.9m$100.5m$11.2m−$34.0m−$9.4m−$44.8m
Dividends paid—————−$904,000−$2.0m———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$1.44bn$1.35bn$1.47bn$1.44bn$1.42bn$1.33bn$1.35bn$1.28bn
Operating income$85.1m$77.2m$91.5m$84.5m$82.7m$79.2m$87.0m$85.1m
Net income$53.9m$45.3m$58.5m$51.8m$50.5m$46.7m$60.1m$53.9m
Diluted earnings per share0.350.290.370.320.320.290.350.32
Cash from operations$183.0m−$12.0m$35.0m$139.0m$90.0m−$7.0m$36.0m$160.0m
Capital spending−$9.0m−$9.0m−$18.0m−$18.0m−$9.0m−$9.0m−$10.0m−$9.0m
Free cash flow$174.0m−$21.0m$17.0m$121.0m$81.0m−$16.0m$26.0m$151.0m
Total assets$3.38bn$3.38bn$3.46bn$3.48bn$3.38bn$3.31bn$3.42bn$3.43bn
Cash and short-term investments$193.8m$177.3m$232.6m$309.8m$198.8m$171.4m$412.6m$483.0m
Debt$1.18bn$1.18bn$1.18bn$1.19bn$1.13bn$1.13bn$1.13bn$1.13bn
Shareholders' equity$1.26bn$1.35bn$1.33bn$1.36bn$1.36bn$1.35bn$1.40bn$1.43bn

Financial ratios

Data as of 18 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin6.1%6.7%9.5%6.6%5.3%3.4%
Net margin3.7%4.2%6.2%3.8%4.1%-0.3%
Return on equity15.7%15.1%18.8%10.9%11.9%-0.8%
Return on assets6.0%6.2%8.0%4.7%5.0%-0.3%
Free cash flow yield6.0%6.8%7.5%5.3%4.1%2.8%
Revenue growth13.0%16.2%9.1%14.7%13.4%31.3%
Earnings growth-2.0%-20.7%77.4%7.6%-1832.3%-89.4%
Current ratio1.53x1.70x1.77x1.76x1.55x1.51x
Debt to equity0.89x0.81x0.76x0.78x0.92x1.13x
Equity ratio38.4%41.0%42.7%42.9%42.1%38.4%
Interest coverage5.48x5.49x6.59x4.73x3.31x1.12x
Buybacks as a share of market value6.0%4.4%2.9%0.5%-3.2%-1.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.7%13.3%19.1%
Operating income12.0%25.0%—
Net income11.3%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin6.2%6.7%6.2%4.1%
Net margin3.9%4.4%3.8%1.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings24.518.622.436.637.4-345.5-34.7-373.9-28.9-14.3
Price to sales0.90.81.41.41.50.91.11.22.30.7

Market value over time

30 Nov 2016 to 16 Oct 2026, in USD

$132.2m$4.86bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return42%-30%10%14%77%5%-6%41%148%11%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 4-to-1 reverse split · 3 Feb 2020
  • 1-to-1 reverse split · 7 Aug 2019

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.